Head-To-Head Comparison: INVO Fertility (NASDAQ:IVF) versus Alignment Healthcare (NASDAQ:ALHC)

Alignment Healthcare (NASDAQ:ALHC) and INVO Fertility (NASDAQ:IVF) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.

Earnings and Valuation

This table compares Alignment Healthcare and INVO Fertility”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alignment Healthcare	$3.95 billion	0.71	-$720,000.00	$0.19	71.26
INVO Fertility	$6.84 million	0.36	-$25.13 million	($33.83)	-0.03

Alignment Healthcare has higher revenue and earnings than INVO Fertility. INVO Fertility is trading at a lower price-to-earnings ratio than Alignment Healthcare, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Alignment Healthcare and INVO Fertility’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Alignment Healthcare	0.89%	20.02%	3.46%
INVO Fertility	-116.29%	-85.54%	-31.05%

Volatility & Risk

Alignment Healthcare has a beta of 1.11, suggesting that its share price is 11% more volatile than the S&P 500. Comparatively, INVO Fertility has a beta of 2.34, suggesting that its share price is 134% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current recommendations for Alignment Healthcare and INVO Fertility, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alignment Healthcare	0	4	7	0	2.64
INVO Fertility	1	0	0	1	2.50

Alignment Healthcare currently has a consensus target price of $23.60, indicating a potential upside of 74.30%. INVO Fertility has a consensus target price of $20.00, indicating a potential upside of 1,930.46%. Given INVO Fertility’s higher possible upside, analysts plainly believe INVO Fertility is more favorable than Alignment Healthcare.

Insider & Institutional Ownership

86.2% of Alignment Healthcare shares are held by institutional investors. Comparatively, 12.0% of INVO Fertility shares are held by institutional investors. 5.2% of Alignment Healthcare shares are held by company insiders. Comparatively, 0.4% of INVO Fertility shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Alignment Healthcare beats INVO Fertility on 12 of the 15 factors compared between the two stocks.

About Alignment Healthcare

Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

About INVO Fertility

INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.